Table 4.
Pre-consultation period | ≤ 12 months no. cases (%) 95% CI | > 12 months no. cases (%) 95% CI |
---|---|---|
No. patients | 36 | 347 |
HIV infection | 0 | 1 (0.3) [0.04–2.1] |
HBV infection | ||
Negative | 29 (90) [72.7–96.8] | 270 (80.9) [76.4–84.8] |
Past infection | 2 (6.6) [1.6–23.5] | 57 (16.9) [13.3–21.4] |
Acute infection | 0 | 1 (0.3) [0.04–2] |
Chronic infection | 1 (3.3) [0.4–20.8] | 5 (1.5) [0.6–3.5] |
HCV infection | ||
Negative | 31 (96.6) [79.1–99.5] | 322 (97) [94.5–98.4] |
HCVAb+/PCR not done | 0 | 0 |
HCVAb+/PCR negative | 1 (3.3) [0.4–20.8] | 10 (3) [1.6–5.4] |
HCVAb+/PCR positive | 0 | 0 |
Syphilis | 2 (6.9) [1.6–24.2] | 3 (1) [0.2–2.8] |
Latent tuberculosis infection | 5 (22.7) [9.5–44.9] | 84 (33.2) [27.4–38.9] |
Intestinal parasites | 2 (7.4) [1.8–25.8] | 4 (1.6) [0.6–4.2] |
Chagas disease | 8 (28) [13.7–48.7] | 164 (49.8) [44.4–55.2] |
Malaria | 0 | 0 |
Schistosomiasis | 0 | 0 |
Eosinophilia | 4 (9) [2.9–25.7] | 49 (14.4) [11.1–18.5] |
The percentages have been calculated as number of cases divided by number of patients to whom the test was performed in each group. HIV = human immunodeficiency virus; HBV = hepatitis B virus; HCV = hepatitis C virus; Ab = antibody; PCR = polymerase chain reaction; 95% CI = 95% confident interval.